| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 727,4 k € | +16.7% | 623,1 k € | ||||||||||||||||||
| Gross margin | 1,4 M € | -4.2% | 1,5 M € | -20.2% | 1,8 M € | +57.0% | 1,2 M € | +15.7% | 1,0 M € | -8.3% | 1,1 M € | -19.6% | 1,4 M € | -0.5% | 1,4 M € | +10.5% | 1,3 M € | +57.6% | 793,1 k € | -19.1% | 980,3 k € | +34.4% | 729,2 k € | -2.9% | 750,6 k € | +23.1% | 609,6 k € | +32.1% | 461,5 k € | -26.4% | 627,5 k € | -4.1% | 654,2 k € | +18.9% | 550,1 k € | +22.4% | 449,4 k € | |
| EBITDA | 1,4 M € | -5.5% | 1,5 M € | -20.1% | 1,8 M € | +57.3% | 1,2 M € | +15.9% | 1,0 M € | -8.4% | 1,1 M € | -19.1% | 1,4 M € | -1.0% | 1,4 M € | +11.0% | 1,2 M € | +57.3% | 785,5 k € | -19.3% | 972,8 k € | +34.4% | 723,9 k € | -2.9% | 745,7 k € | +24.0% | 601,6 k € | +32.6% | 453,7 k € | -27.5% | 625,6 k € | -3.8% | 650,5 k € | +19.0% | 546,6 k € | +23.3% | 443,5 k € | |
| Operating profit | 1,3 M € | -6.0% | 1,3 M € | -21.7% | 1,7 M € | +64.6% | 1,0 M € | +14.1% | 912,3 k € | -9.6% | 1,0 M € | -14.8% | 1,2 M € | -7.6% | 1,3 M € | +12.1% | 1,1 M € | +77.2% | 646,1 k € | -23.4% | 843,8 k € | +38.4% | 609,8 k € | -1.3% | 617,7 k € | +45.0% | 426,1 k € | +32.9% | 320,7 k € | -31.7% | 469,7 k € | -7.1% | 505,9 k € | +2.3% | 494,4 k € | +29.8% | 380,8 k € | |
| Profit/loss | 937,1 k € | -2.8% | 964,1 k € | -17.7% | 1,2 M € | +63.0% | 718,4 k € | +16.8% | 615,1 k € | -5.9% | 653,8 k € | -15.7% | 775,6 k € | -1.7% | 788,7 k € | +17.4% | 672,0 k € | +82.4% | 368,4 k € | -33.4% | 552,8 k € | +34.0% | 412,5 k € | -0.4% | 413,9 k € | +36.7% | 302,7 k € | +32.3% | 228,9 k € | -27.9% | 317,6 k € | -4.5% | 332,5 k € | +12.4% | 295,7 k € | +27.9% | 231,2 k € | |
| Equity | 6,1 M € | +18.2% | 5,2 M € | -28.3% | 7,2 M € | +19.4% | 6,0 M € | +13.5% | 5,3 M € | +13.1% | 4,7 M € | +16.2% | 4,0 M € | -23.7% | 5,3 M € | +17.5% | 4,5 M € | +17.5% | 3,8 M € | +10.6% | 3,5 M € | +293.2% | 882,3 k € | -67.3% | 2,7 M € | +18.1% | 2,3 M € | +17.3% | 2,0 M € | +13.3% | 1,7 M € | +22.6% | 1,4 M € | +31.0% | 1,1 M € | +50.9% | 710,0 k € | |
| Total assets | 6,3 M € | -24.5% | 8,3 M € | +8.8% | 7,6 M € | +15.2% | 6,6 M € | +9.3% | 6,1 M € | +7.3% | 5,6 M € | +8.2% | 5,2 M € | -8.2% | 5,7 M € | +16.4% | 4,9 M € | +14.0% | 4,3 M € | +6.5% | 4,0 M € | +11.0% | 3,6 M € | +15.8% | 3,1 M € | +14.5% | 2,7 M € | +27.5% | 2,1 M € | +10.6% | 1,9 M € | +15.1% | 1,7 M € | +19.8% | 1,4 M € | +29.4% | 1,1 M € | |
| Cash | 405,6 k € | -79.3% | 2,0 M € | -53.8% | 4,2 M € | +58.6% | 2,7 M € | -3.3% | 2,8 M € | -8.5% | 3,0 M € | +12.5% | 2,7 M € | +8.0% | 2,5 M € | +45.9% | 1,7 M € | +59.4% | 1,1 M € | -48.7% | 2,1 M € | +28.8% | 1,6 M € | +108.5% | 776,1 k € | +149.3% | 311,3 k € | -61.3% | 803,7 k € | +137.0% | 339,1 k € | +181.1% | 120,6 k € | -77.7% | 541,1 k € | +830.3% | 58,2 k € | |
| Debts | 151,2 k € | -95.2% | 3,1 M € | +707.6% | 386,6 k € | -33.3% | 580,0 k € | -21.9% | 742,5 k € | -21.5% | 945,8 k € | -18.8% | 1,2 M € | +204.9% | 382,0 k € | +2.8% | 371,5 k € | -16.3% | 443,8 k € | +0.9% | 439,9 k € | -83.5% | 2,7 M € | +523.9% | 426,5 k € | -4.2% | 445,2 k € | +129.5% | 194,0 k € | -10.4% | 216,4 k € | -18.8% | 266,6 k € | -20.2% | 334,2 k € | -10.0% | 371,5 k € | |
Private limited company · Brugge · incorporated on 24/04/1996
Private limited company profitable and well capitalised. Cash position declining (-79.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. DILLEMANS - ALGEMENE CHIRURGIE is a Private limited company incorporated in 1996. Its main activity is: Specialist medical practice activities. Its registered office is in Brugge.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette